Scientists discover that CoQ10 can program cancer cells to

New Post Public Reply Private Reply Replies (0) Message Board
wowhappens28
222
Scientists discover that CoQ10 can program cancer cells to self-destruct.

Some stories I wonder about, too good to be true?

https://www.naturalhealth365.com/coq10-cancer...-2380.html

(NaturalHealth365) It has been 60 years since the discovery of CoQ10, a vitamin-like substance first identified by Nobel Prize-winning scientist Frederick Crane. Currently used to help treat heart disease, CoQ10 may have even more therapeutic benefits to offer – especially for cancer patients.
A promising study shows that this nutrient causes cancer cells to self-destruct before they can multiply – giving rise to hopes that it can be utilized as an important integrative therapy for cancer patients. Let’s take a closer look at this wonderful scientific work.
CoQ10 “reminds” cancer cells to die
Coenzyme Q10 (CoQ10) – which supports many indispensable biochemical reactions – is also called “ubiquinone.” This is due to its ubiquitous nature – CoQ10 is found in nearly every human cell, with particularly high concentrations in the mitochondria, the powerhouses of the cell.
Researchers have found that CoQ10 is vital in producing adenosine triphosphate, the “energy molecule” (ATP). In addition, it is a potent antioxidant that boosts immune health and energy.
But CoQ10 may have an even more important function to perform. Researchers report that the out-of-control replication characteristic of cancer cells is a result of the cells’ lost capacity to respond to programmed cell death, or apoptosis. An exciting study shows that CoQ10 brings this ability back – by modulating the protein which causes the resistance to cell death in the first place.
CoQ10 suppressed the growth of cancer cells and reduced tumor growth
To conduct the study, researchers at the University of Miami added CoQ10 to prostate cancer cells – and found a 70 percent inhibition in growth over 48 hours, along with a reversal in the anti-apoptotic protein bcl-2. Adding CoQ10 to breast cancer cells also inhibited proliferation, without harming healthy cells.
The team noted that treating a culture of melanoma cells with CoQ10 resulted in the death of all cancer cells within hours – and that applying CoQ10 topically to mice with melanoma tumors caused a 55 percent reduction in tumor mass. There was also a “profound disruption” of tumor vasculature – the structure of veins needed by tumors for oxygen and nutrition.
According to lead investigator Dr. S. L. Hsia, “This is the first time in history we have been able to selectively teach a cancer cell to kill itself with CoQ10…without harming healthy cells.”
The findings were presented at a meeting of the American Association for Cancer Research in Anaheim, CA.
Additional studies show anti-cancer effects
Researchers have also examined CoQ10’s ability to help prevent damaging side effects from chemotherapy drugs such as tamoxifen, used to treat breast cancer.
In one study, rats with chemically induced breast cancer were given CoQ10 along with tamoxifen, and displayed significant improvements in the function of their antioxidant enzymes – a development that could potentially help to mitigate oxidative damage. CoQ10 has also been found to reduce chemotherapy-associated damage to the mitochondria of the heart.
A groundbreaking study published in 1994 in Molecular Aspects of Medicine involved 32 high-risk patients with breast cancer that had spread to the lymph nodes. The group was studied for 18 months, following a nutritional intervention that involved 90 mgs a day of CoQ10 – along with vitamin C, vitamin E, beta-carotene, selenium and essential fatty acids.
Although the expected number of deaths was four, not one of the patients in the study died. In addition, quality of life improved, use of pain medication decreased, and six patients showed apparent partial remissions – a stunning result.
CoQ10 may also help combat cancer by strengthening the immune system. Studies have shown that CoQ10 and vitamin B-6 together can boost blood levels of disease-fighting immune system cells known as T-4 lymphocytes.
Looks like CoQ10 supplementation is a wise choice
Researchers agree that decreased CoQ10 levels are associated with poor health, with low levels seen in cancer patients and those with other chronic illnesses. Moreover, many scientists believe that having low levels of CoQ10 can damage cell DNA.
The use of statin drugs can cause CoQ10 levels to drop, as can viral infection, strenuous exercise, and cancer. Normal aging plays a role as well, with natural stores of CoQ10 beginning to decrease by age 20.
Foods rich in CoQ10 include cold-water, oily fish such as sardines and mackerel. Liver, peanuts and whole grains are also good sources. But, because dietary intake isn’t always sufficient, supplementation may be advisable – especially for aging adults, breast cancer patients, and people taking statin drugs.
Before taking CoQ10, first get the go-ahead from a knowledgeable integrative physician. If you have cancer, your doctor can help you determine if CoQ10 is an appropriate integrative therapy. In addition, natural health experts tend to recommend supplement doses of CoQ10 ranging from 30 to 200 mg a day, while some clinical studies have used dosages up to 500 mg.
For maximum benefit, CoQ10 should be taken with a meal that contains some fat.
Research into CoQ10’s possible anticancer effects is ongoing, with various studies suggesting that CoQ10, when integrated with conventional cancer treatment, could be an effective anti-tumor agent, and may reduce the harm produced by chemotherapy medications. There is no doubt that this non-toxic natural nutrient deserves a closer look.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Wave Kids™ Unveils New Flavors for Kids' Drinks

Updated Category News Views 1

Sparking a Fresh Wave in the Kids' Beverage Market Alright, let me tell you about a new player plowing into the kids' drink scene. Wave Kids™, a brand that's making waves—pun intended—has a fresh lineup that screams 'fun' and 'healthy' in equal measure. Just coinciding with back-to-school season, this Scottsdale, Arizona outfit has rolled out not one or two, but...

Continue Reading
LeoLabs and SciTec Partner for $93.7M Space Force Deal

Updated Category News Views 1

LeoLabs and SciTec Join Forces for Space Dominance The space race ain't just about rockets blasting off anymore. It's about making sure we've got eyes everywhere, even on the back of our heads, so to speak. Enter LeoLabs teaming up with SciTec to help the U.S. Space Force upgrade their radar systems to something out of a sci-fi flick, armed with a $93.7 million contract...

Continue Reading
Fresh Thyme Empowers Local Brands in Michigan Debut

Updated Category News Views 1

A Community-Driven Retail Innovation The grocery game just got a little more personal in Michigan, and we're not talking about run-of-the-mill retail pitches. Fresh Thyme Market, known for its commitment to local and natural products, is shaking things up with their Pitch Thyme Competition. This ain’t your usual product presentation. It’s a whole new ball game where...

Continue Reading
Muscle Car Fever Revs Up in New Global TV Series

Updated Category News Views 2

Chasing the Dream on Wheels Amid the buzz of New York, there's a roar building up that's hard to ignore. It's a sound that echoes through time, capturing the imagination of petrol heads everywhere—those legendary American muscle cars are back in the limelight. I mean, who hasn't dreamt of launching down a highway in a '69 Ford Mustang? 'The Hunt for Rolling Treasure' is...

Continue Reading
Agroz's Big Leap: New Supply Deal in Malaysia

Updated Category News Views 1

Agroz Inc. Executes a Game-Changing Deal If anyone thought the ag tech players were sitting idle, think again. Agroz Inc., noted for their innovative controlled-environment agriculture, just inked a pivotal deal with Harvest Hive in Malaysia. It's not just a nod to expansion—it's a strategic leap into the big leagues. Picture this: Harvest Hive's sprawling 500-acre farm...

Continue Reading
MCatalysis Secures $5M to Disrupt Fuel Cost Dynamics

Updated Category News Views 1

Funding Fuels Innovation MCatalysis has just secured a hefty $5 million in seed funding to throw down with the big dogs in energy production. This isn't your regular backyard science project; this company is serious about changing the game with a tech-driven approach that could undercut current fuel prices. HL Energy Ventures and Oxford Science Enterprises are backing...

Continue Reading
IDX Expands, Enhances Team Amid 56% H1 Growth

Updated Category News Views 3

IDX's Aggressive Global Expansion Here's a tip from a trader who’s seen cycles rise and fall: watch the movers who're playing the long game, putting down roots worldwide while making headway in the data game. IDX has clearly mapped out this trajectory as evidenced by its recent grab in the global strategic communications ring. IDX's bustling around like a squirrel...

Continue Reading
Spot the Signs: Early Gum Disease Insights from Experts

Updated Category News Views 2

Why Early Detection of Gum Disease Matters Let's dive right into the crux of things. Gum disease, that sneaky antagonist of oral health, starts unassumingly. You brush, you floss, but those gums might still bleed—ever noticed? Dr. Marian Burgard of Fairport Family Dental has a thing or two to say about this, enlightening us through an insightful piece by HelloNation....

Continue Reading
ZEEKR's Shooting Brakes Dominate: Over 400K Sold

Updated Category News Views 2

ZEEKR's Stellar Performance in a Crowded Market Another month, another bumper crop for ZEEKR's shooting brakes. These beauties aren't just hanging in there; they're leading the pack. In August alone, global deliveries marched past the 10,000 mark for the third month running—a feat not easily achieved in today's saturated automotive landscape. It's no wonder the...

Continue Reading
Everpure Surges into the S&P 500: A Milestone Move

Updated Category News Views 10

Big Leagues Beckon: Everpure Enters the S&P 500 Another day, another dollar, but today ain't just any day for Everpure. They’re stepping up from the minor leagues and grabbing their spot in the illustrious S&P 500 lineup. We're talking about a milestone that every company dreams of, but few achieve—this ain't your regular Tuesday headline. Stock Market's Stamp of...

Continue Reading

Top 5 Most Recently Viewed Articles

Virtual Desktop Infrastructure Market Growth Driven by Trends

Updated Category News Views 238

Understanding the Virtual Desktop Infrastructure Market Dynamics The virtual desktop infrastructure (VDI) market is an evolving landscape that has recently gained remarkable attention. As organizations embrace digital transformation, the demand for effective VDI solutions continues to surge, driving the market's anticipated growth. Market Growth Insights Recent analyses...

Continue Reading
GHOST® Strengthens Presence in Sports with New Partnership

Updated Category News Views 342

GHOST® pulled the trigger on a major deal back in 2024, signing on as the Founding Partner and Official Energy Drink of the College Basketball Crown. You could almost hear the desks buzzing when this news hit; it’s not every day you see a lifestyle brand like GHOST® making waves in sports. The Partnership Dynamics: Game-Changer or Just Hype? Now, this tournament was...

Continue Reading
CenterPoint Energy Welcomes New Board Members to Drive Growth

Updated Category News Views 265

CenterPoint Energy Introduces New Board Members CenterPoint Energy is bringing new energy to its Board of Directors by electing two highly experienced individuals, Manuel Miranda and Laurie Fitch. This strategic addition aligns with the company's utility and customer-oriented vision, enhancing its commitment to providing reliable services. New Directors with Exceptional...

Continue Reading
Investigation Launched for PACS Group, Inc. Shareholders

Updated Category News Views 22

Investigation Into PACS Group, Inc. Shareholders' Claims Recently, an investigation has been initiated by Wolf Popper LLP, focused on potential claims regarding PACS Group, Inc. known as "PACS". This inquiry concerns purchases of PACS common stock with the aim of ensuring investors are informed about their rights and options in light of recent developments. Overview of...

Continue Reading
PRFoods Reports Q1 Performance Amid Market Challenges

Updated Category News Views 192

Management Commentary on Q1 Financial Performance Overview PRFoods has entered its financial year under a cloud of economic uncertainty, which is resulting in altered consumer behavior and a challenging market. For the latest quarter, PRFoods reported a sales revenue of €3.6 million, marking a decline of 21% compared to last year. This downturn was prominently led by...

Continue Reading